Steroidogenic factor-1 inverse agonists as a treatment option for canine hypercortisolism: in vitro study

This publication has 50 references indexed in Scilit:

• Evaluation of twice-daily lower-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism
  Journal of the American Veterinary Medical Association, 2011
• Expression of the ACTH receptor, steroidogenic acute regulatory protein, and steroidogenic enzymes in canine cortisol-secreting adrenocortical tumors
  Domestic Animal Endocrinology, 2010
• Inhibition of Adrenocortical Carcinoma Cell Proliferation by Steroidogenic Factor-1 Inverse Agonists
  The Journal of Clinical Endocrinology & Metabolism, 2009
• Structure of SF-1 Bound by Different Phospholipids: Evidence for Regulatory Ligands
  Molecular Endocrinology, 2009
• Potent, Selective and Cell Penetrant Inhibitors of SF-1 by Functional Ultra-High-Throughput Screening
  Molecular Pharmacology, 2008
• Synthesis of small molecule inhibitors of the orphan nuclear receptor steroidogenic factor-1 (NR5A1) based on isoquinolinone scaffolds
  Bioorganic & Medicinal Chemistry Letters, 2008
• Cyclic AMP-Stimulated Interaction between Steroidogenic Factor 1 and Diacylglycerol Kinase θ Facilitates Induction of CYP17
  Molecular and Cellular Biology, 2007
• Crystallographic Identification and Functional Characterization of Phospholipids as Ligands for the Orphan Nuclear Receptor Steroidogenic Factor-1
  Molecular Cell, 2005
• Indicators of Malignancy of Canine Adrenocortical Tumors: Histopathology and Proliferation Index
  Veterinary Pathology, 2004
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^−ΔΔC_T Method
  Methods, 2001